These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6510485

  • 21. c-kit<low Pluripotent hemopoietic stem cells form CFU-S on day 16.
    Lian Z, Feng B, Sugiura K, Inaba M, Yu C, Jin T, Fan T, Cui Y, Yasumizu R, Toki J, Adachi Y, Hisha H, Ikehara S.
    Stem Cells; 1999; 17(1):39-44. PubMed ID: 10215400
    [Abstract] [Full Text] [Related]

  • 22. The effects of calusterone on hemopoiesis in mice after busulfan-induced suppression of hemopoietic stem cells.
    Porcellini A, Manna A, Grilli G, Rizzoli V, Shadduck RK.
    J Lab Clin Med; 1981 Jun; 97(6):801-11. PubMed ID: 6453178
    [Abstract] [Full Text] [Related]

  • 23. Gamma irradiation of the fetus damages the developing hemopoietic microenvironment rather than the hemopoietic progenitor cells.
    Yang FT, Lord BI, Hendry JH.
    Radiat Res; 1995 Mar; 141(3):309-13. PubMed ID: 7871158
    [Abstract] [Full Text] [Related]

  • 24. Transient erythropoietic spleen colonies: effects of erythropoietin in normal and genetically anemic W/Wv mice.
    Gregory CJ, McCulloch EA, Till JE.
    J Cell Physiol; 1975 Aug; 86(1):1-8. PubMed ID: 1176537
    [Abstract] [Full Text] [Related]

  • 25. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
    Pannacciulli I, Massa G, Bogliolo G, Ghio R, Sobrero A.
    Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
    [Abstract] [Full Text] [Related]

  • 26. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 27. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
    Robinson S, van Os R, Sheridan T, Mauch P.
    Stem Cells; 2000 Dec; 18(2):93-101. PubMed ID: 10742381
    [Abstract] [Full Text] [Related]

  • 28. Derivatives of benzo(c)fluorene. XI. Effect of Benfluron on hemopoietic stem cells.
    Hrubá A, Paluska E, Pujman V, Polednová V, Chudomel V, Krepelka J.
    Neoplasma; 1984 Dec; 31(4):407-13. PubMed ID: 6472513
    [Abstract] [Full Text] [Related]

  • 29. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability.
    Balint B, Ivanović Z, Petakov M, Taseski J, Jovcić G, Stojanović N, Milenković P.
    Bone Marrow Transplant; 1999 Mar; 23(6):613-9. PubMed ID: 10217193
    [Abstract] [Full Text] [Related]

  • 30. Comparison of CFU-GM response to piperazinedione versus cyclophosphamide in normal mice.
    OKunewick JP, Buffo MJ, Kociban DL.
    Exp Hematol; 1984 Jun; 12(5):297-300. PubMed ID: 6547096
    [Abstract] [Full Text] [Related]

  • 31. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC, Gorin NC, Douay L.
    Nouv Rev Fr Hematol (1978); 1995 Jun; 37(2):125-30. PubMed ID: 7644349
    [Abstract] [Full Text] [Related]

  • 32. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 33. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
    Douay L, Giarratana MC, Labopin M, Bardinet D, Bouchet S, Gorin NC.
    Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
    [Abstract] [Full Text] [Related]

  • 34. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 35. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
    Ivanović Z, Bartolozzi B, Bernabei PA, Cipolleschi MG, Milenkovic P, Praloran V, DelloSbarba P.
    Stem Cells; 1999 Feb; 17(4):219-25. PubMed ID: 10437985
    [Abstract] [Full Text] [Related]

  • 36. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 37. Rescue from lethal irradiation correlates with transplantation of 10-20 CFU-S-day 12.
    Pallavicini MG, Redfearn W, Necas E, Brecher G.
    Blood Cells Mol Dis; 1997 Aug; 23(2):157-68. PubMed ID: 9236154
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J, Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 2000 Aug; 18(3):214-9. PubMed ID: 10840075
    [Abstract] [Full Text] [Related]

  • 39. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S, Hellman S, Montgomery M, Ferrara J, Mauch P.
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [Abstract] [Full Text] [Related]

  • 40. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE, Erickson-Miller CL, Murphy MJ.
    Stem Cells; 1997 Jan; 15(4):286-90. PubMed ID: 9253112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.